Contact TB-500 Compound about the editorial record

Editorial inquiries

Use the form below to reach TB-500 Compound about the editorial content of this site. We welcome citation corrections, pointers to peer-reviewed studies we have missed, and questions about how a particular claim is sourced. If you believe a finding has been attributed to the wrong molecule — fragment versus full-length thymosin β4 — tell us which entry and we will check it against the source.

Anything outside the editorial record is beyond what this desk can help with. No line here is medical guidance, TB-500 is neither recommended nor supplied, and there is no clinic, pharmacy, or vendor to point you to. Questions about obtaining the compound fall outside what a research board does and won't get a sourcing reply.

What we are not

This is an editorial research digest. It is not a clinic, not a compounding pharmacy, and not a sales channel. Nothing here is dispensed, prescribed, or sold. For the regulatory picture on compounded access in general terms, see the TB-500 legal status and 503A category page; for the full source list, see the TB-500 references and citations register. For medical questions about your own situation, consult a licensed healthcare professional — not this site.